Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
The EMBO Journal|January 1, 1987
Selection of AUG initiation codons differs in plants and animalsH A Lütcke, K C Chow, F S Mickel, et al.Circulation|June 15, 1995
Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC InvestigatorsF V Aguirre, E J Topol, J J Ferguson, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2000
Ad hoc coronary interventionJ C Blankenship, G J Mishkel, C E Chambers, et al.Journal of the American College of Cardiology|October 1, 1996
Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic ComplicationsJ Lefkovits, J C Blankenship, K M Anderson, et al.Journal of the American College of Cardiology|August 31, 2001
Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trialJ C Blankenship, G Tasissa, J C O'Shea, et al.The American Journal of Cardiology|March 23, 2000
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary ThrombosisM C Thel, R M Califf, B E Tardiff, et al.Journal of the American College of Cardiology|February 6, 1999
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-IIB E Tardiff, R M Califf, J E Tcheng, et al.The American Journal of Cardiology|March 18, 1999
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplastyJ C Blankenship, M W Krucoff, S W Werns, et al.Journal of the American College of Cardiology|June 17, 1998
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary ThrombosisJ S Mandak, J C Blankenship, L H Gardner, et al.Parkinsonism & Related Disorders|August 23, 2011
The relation between depression and parkin genotype: the CORE-PD studyA Srivastava, M-X Tang, H Mejia-Santana, et al.Pageof 6